Airway Management With Supraglottic Devices in Unruptured Intracranial Aneurysms

Completed

• Conditions: Airway Management

• Registration Number: NCT03632902
• Lead Sponsor: Fundacion Clinic per a la Recerca Biomédica

Brief Summary

Endovascular techniques for the treatment of intracranial aneurysms are growing.

Detailed Description

Retrospective analysis of the investigators experience in the last 8 years with the airway management in endovascular therapy for unruptured aneurysms. A total of 206 participants will be included from 2010 to 2018. Airway management (anticipated difficult airway, need for LM repositioning, orotracheal intubation because of failed laryngeal mask insertion, airway complication), intraoperative monitoring, aneurism size and location, intraoperative and perioperative complications will be registered.

Statistics will be compared between groups with t test or x test, as appropriate.

Study Timeline

• Study Start: 2018-06-26
• Study First Submitted: 2018-06-26
• Study First Submitted QC: 2018-08-12
• Study First Posted: 2018-08-16
• Primary Completion: 2019-10-20
• Study Completion: 2019-11-20
• Status Verified: 2020-05
• Last Update Submitted: 2020-05-27
• Last Update Posted: 2020-05-28

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 205

Inclusion Criteria

• patients that underwent endovascular treatment for unruptured aneurysm

Exclusion Criteria

• ruptured aneurysm

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Security in the use of supraglottic devices in the unruptured intracranial aneurysms.	ten years	security; the incidence of adverse events during the procedure and post-procedure will be recorded, also morbidity and mortality in patients managed with supraglottic devices during unruptured aneurysm embolization

Trial Locations

Locations (1)

Hospital Clinic; 🇪🇸 Barcelona, Cataluña, Spain